|
|
Volumn 76, Issue 6, 1999, Pages 325-330
|
|
What is the place of genetics in the pathogenesis of pre-eclampsia?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSINOGEN;
BLOOD CLOTTING FACTOR 5;
COPPER ZINC SUPEROXIDE DISMUTASE;
DIPEPTIDYL CARBOXYPEPTIDASE;
HLA DR ANTIGEN;
HLA G ANTIGEN;
TUMOR NECROSIS FACTOR ALPHA;
ARTERY;
CHROMOSOME 1;
CHROMOSOME 17;
CHROMOSOME 18;
CHROMOSOME 21;
CHROMOSOME 3;
CHROMOSOME 4;
CHROMOSOME 6;
CHROMOSOME 9;
CHROMOSOME MAP;
DECIDUA;
DISEASE PREDISPOSITION;
EDITORIAL;
ENVIRONMENTAL FACTOR;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PEDIGREE;
PHENOTYPE;
PREECLAMPSIA;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ANGIOTENSINOGEN;
CHROMOSOMES, HUMAN, PAIR 1;
FACTOR V;
FEMALE;
HUMANS;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
MUTATION;
OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS;
PRE-ECLAMPSIA;
PREGNANCY;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RECEPTOR, ANGIOTENSIN, TYPE 2;
RECEPTORS, ANGIOTENSIN;
|
|
EID: 0032732561
PISSN: 00063126
EISSN: None
Source Type: Journal
DOI: 10.1159/000014175 Document Type: Editorial |
|
Times cited : (50)
|
|
References (32)
|
